MedPath
HSA Product

SEMGLEE™ SOLUTION FOR INJECTION IN A PREFILLED PEN 100U/ML

Product approved by Health Sciences Authority (SG)

Basic Information

SEMGLEE™ SOLUTION FOR INJECTION IN A PREFILLED PEN 100U/ML

INJECTION, SOLUTION

Regulatory Information

SIN16009P

September 14, 2020

Prescription Only

Therapeutic

SUBCUTANEOUS

August 10, 2023

June 4, 2025

XA10AE04

Company Information

Biocon Sdn. Bhd.

MYLAN PHARMACEUTICALS PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Active Ingredients

Insulin glargine

Strength: 3.64 mg/ml

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section “List of Excipients” – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

Indication Information

**Therapeutic indications** For the treatment of adults, adolescents and children of 6 years or above with diabetes mellitus, where treatment with insulin is required.

© Copyright 2025. All Rights Reserved by MedPath